Paradigm Biopharmaceuticals ( ($AU:PAR) ) has shared an announcement. Paradigm Biopharmaceuticals has confirmed it has enrolled or randomised ...

Both Hardee's locations in Topeka closed their doors over the weekend of Dec. 20. Signage at the 2424 SW 6th Ave. and 2100 SW ...

The fast-food burger sector has faced competitive challenges this year, which has led to several chain operators closing restaurant locations. Economic issues such as low profit margins, decreased ...

Cardano is moving beyond a single‑chain paradigm. At the center of this vision are interchains, which connect Cardano to a ...

Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More Aeris Resources dropping 6% as recent capital ...

Right now, the debate about consciousness often feels frozen between two entrenched positions. On one side sits computational ...

London's Paradigm Distillery is marking the holiday season with the release of a limited-edition 28-year-old whisky. A London ...

English and writing studies professor Jane Toswell chose a 15th century rare book for Western Libraries as part of a family gift in honour of her father.

Recent research from the Medical University of South Carolina laboratory of Russell Norris, Ph.D., challenges the notion that ...

Soin Neuroscience and BIOTRONIK Neuro today announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscience's proprietary waveform technology.

A new study challenges what's long been assumed about genetic variants thought to always cause inherited blindness.